跳至主要内容
临床试验/NCT02236429
NCT02236429进行中(未招募)不适用

Vaginal Flora Transplantation for Recurrent Bacterial Vaginosis

Hadassah Medical Organization1 个研究点 分布在 1 个国家目标入组 10 人开始时间: 2015年6月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
10
试验地点
1
主要终点
relief of bacterial vaginosis

研究概览

简要总结

Bacterial vaginosis (BV) is the most common vaginal infection in women. It is caused by a vaginal bacterial imbalance. Treatment with antibiotics is the standard of care but there is a high rate of recurrence. Almost half of women successfully treated suffer a recurrence within three months. Complications include risk factors for premature birth, increased transmission of sexually transmitted diseases and higher risk for carcinoma of cervix. The investigators proposed study is a cost effective treatment based on returning the normal microbial balance to the vagina. The investigators propose to transfer normal vaginal flora from healthy individuals to women with BV and thus restore normal vaginal flora and cure this disorder.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 50 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • recurrent BV (4 or more incidences in the past year)
  • recurrence of BV in less than 2 months of antibiotic treatment or need for prophylactic antibiotic
  • 3/4 Amsel criteria and Nugent criteria greater or equal to 7

排除标准

  • pregnancy or planned pregnancy during the study period
  • other known diseases
  • carriers of Hep B and C
  • HIV or syphilis positive

研究组 & 干预措施

recurrent bacterial vaginitis

Experimental

干预措施: vaginal flora transplant (Biological)

结局指标

主要结局

relief of bacterial vaginosis

时间窗: 12 month

Clinical cure, i.e., absence of vaginal discharge and malodor

次要结局

  • Laboratory parameters(12 months)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Vaginal Flora for Treatment of Bacterial Vaginosis | 临床试验